Abbott Laboratories Net Income 2010-2025 | ABT

Abbott Laboratories annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Abbott Laboratories net income for the quarter ending March 31, 2025 was $1.325B, a 8.16% increase year-over-year.
  • Abbott Laboratories net income for the twelve months ending March 31, 2025 was $13.502B, a 139.82% increase year-over-year.
  • Abbott Laboratories annual net income for 2024 was $13.402B, a 134.18% increase from 2023.
  • Abbott Laboratories annual net income for 2023 was $5.723B, a 17.45% decline from 2022.
  • Abbott Laboratories annual net income for 2022 was $6.933B, a 1.95% decline from 2021.
Abbott Laboratories Annual Net Income
(Millions of US $)
2024 $13,402
2023 $5,723
2022 $6,933
2021 $7,071
2020 $4,495
2019 $3,687
2018 $2,368
2017 $477
2016 $1,400
2015 $4,423
2014 $2,284
2013 $2,576
2012 $5,963
2011 $4,728
2010 $4,626
2009 $5,746
Abbott Laboratories Quarterly Net Income
(Millions of US $)
2025-03-31 $1,325
2024-12-31 $9,229
2024-09-30 $1,646
2024-06-30 $1,302
2024-03-31 $1,225
2023-12-31 $1,594
2023-09-30 $1,436
2023-06-30 $1,375
2023-03-31 $1,318
2022-12-31 $1,033
2022-09-30 $1,435
2022-06-30 $2,018
2022-03-31 $2,447
2021-12-31 $1,989
2021-09-30 $2,100
2021-06-30 $1,189
2021-03-31 $1,793
2020-12-31 $2,162
2020-09-30 $1,232
2020-06-30 $537
2020-03-31 $564
2019-12-31 $1,049
2019-09-30 $960
2019-06-30 $1,006
2019-03-31 $672
2018-12-31 $654
2018-09-30 $563
2018-06-30 $733
2018-03-31 $418
2017-12-31 $-828
2017-09-30 $603
2017-06-30 $283
2017-03-31 $419
2016-12-31 $798
2016-09-30 $-329
2016-06-30 $615
2016-03-31 $316
2015-12-31 $767
2015-09-30 $580
2015-06-30 $784
2015-03-31 $2,292
2014-12-31 $905
2014-09-30 $538
2014-06-30 $466
2014-03-31 $375
2013-12-31 $590
2013-09-30 $966
2013-06-30 $476
2013-03-31 $544
2012-12-31 $1,053
2012-09-30 $1,943
2012-06-30 $1,725
2012-03-31 $1,242
2011-12-31 $1,619
2011-09-30 $303
2011-06-30 $1,943
2011-03-31 $864
2010-12-31 $1,441
2010-09-30 $891
2010-06-30 $1,292
2010-03-31 $1,003
2009-12-31 $1,539
2009-09-30 $1,480
2009-06-30 $1,288
2009-03-31 $1,439
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $220.159B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $157.028B 37.51
Stryker (SYK) United States $154.023B 32.21
EssilorLuxottica (ESLOY) France $136.572B 0.00
Medtronic (MDT) Ireland $119.200B 16.90
Lonza Group Ag (LZAGY) Switzerland $50.282B 0.00
Haleon (HLN) United Kingdom $44.384B 25.33
ResMed (RMD) United States $40.346B 30.30
GE HealthCare Technologies (GEHC) United States $35.536B 16.87
Agilent Technologies (A) United States $34.139B 22.26
Terumo (TRUMY) Japan $25.843B 33.57
Koninklijke Philips (PHG) Netherlands $25.190B 17.68
Insulet (PODD) United States $20.424B 80.17
Zimmer Biomet Holdings (ZBH) United States $19.300B 12.40
Baxter (BAX) United States $14.995B 11.19
Smith & Nephew SNATS (SNN) United Kingdom $13.871B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $7.189B 25.02
Lantheus Holdings (LNTH) United States $5.046B 12.73
Perrigo (PRGO) Ireland $3.908B 9.91
Prestige Consumer Healthcare (PBH) United States $3.799B 16.97
Haemonetics (HAE) United States $3.613B 16.45
Envista Holdings (NVST) United States $3.525B 29.30
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.197B 23.58
LeMaitre Vascular (LMAT) United States $1.862B 41.63
QuidelOrtho (QDEL) United States $1.852B 12.74
AtriCure (ATRC) United States $1.559B 0.00
Acuren (TIC) United States $1.441B 0.00
Green Thumb Industries (GTBIF) United States $1.332B 29.95
AdaptHealth (AHCO) United States $1.274B 12.93
Phibro Animal Health (PAHC) United States $1.183B 15.12
Neogen (NEOG) United States $1.133B 14.50
BioLife Solutions (BLFS) United States $1.080B 0.00
Curaleaf Holdings (CURLF) Canada $0.964B 0.00
InMode (INMD) Israel $0.930B 9.38
Kestra Medical Technologies (KMTS) United States $0.850B 0.00
Tilray Brands (TLRY) Canada $0.693B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.685B 0.00
Valneva SE (VALN) France $0.654B 0.00
Evolus (EOLS) United States $0.614B 0.00
Owens & Minor (OMI) United States $0.609B 5.05
CeriBell (CBLL) United States $0.547B 0.00
ZimVie (ZIMV) United States $0.521B 23.70
Surmodics (SRDX) United States $0.515B 0.00
SNDL (SNDL) Canada $0.398B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.359B 0.00
Cresco Labs (CRLBF) United States $0.336B 0.00
Sanuwave Health (SNWV) United States $0.324B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.89
Capricor Therapeutics (CAPR) United States $0.322B 0.00
Quanterix (QTRX) United States $0.292B 0.00
Aurora Cannabis (ACB) Canada $0.272B 80.67
Cerus (CERS) United States $0.266B 0.00
OraSure Technologies (OSUR) United States $0.251B 0.00
Viemed Healthcare (VMD) United States $0.242B 20.40
Biote (BTMD) United States $0.236B 6.65
Canopy Growth (CGC) Canada $0.234B 0.00
Verano Holdings (VRNOF) United States $0.230B 0.00
Sanara MedTech (SMTI) United States $0.227B 0.00
Omeros (OMER) United States $0.224B 0.00
Brainsway (BWAY) Israel $0.222B 58.65
Organigram Global (OGI) Canada $0.205B 0.00
Utah Medical Products (UTMD) United States $0.190B 15.65
High Tide (HITI) Canada $0.188B 0.00
TriSalus Life Sciences (TLSI) United States $0.173B 0.00
Vireo Growth (VREOF) United States $0.170B 0.00
Exagen (XGN) United States $0.155B 0.00
TerrAscend (TSNDF) Canada $0.135B 0.00
FitLife Brands (FTLF) United States $0.121B 0.00
MacroGenics (MGNX) United States $0.108B 0.00
Jin Medical (ZJYL) China $0.102B 0.00
Jushi Holdings (JUSHF) United States $0.101B 0.00
Fonar (FONR) United States $0.100B 12.86
Quipt Home Medical (QIPT) United States $0.097B 0.00
Apyx Medical (APYX) United States $0.096B 0.00
Safety Shot (SHOT) United States $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Veru (VERU) United States $0.082B 0.00
Zynex (ZYXI) United States $0.078B 0.00
InterCure (INCR) Israel $0.071B 0.00
Agape ATP (ATPC) $0.066B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.059B 0.00
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.038B 13.29
Nephros (NEPH) United States $0.038B 51.00
Rockwell Medical (RMTI) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.023B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Senestech (SNES) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00